Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports

被引:4
作者
Brockhaus, Lisa [1 ]
Schmid, Yasmin [2 ]
Rast, Anna C. [3 ]
Bravo, Alexandra E. Ratz [2 ,4 ]
Hofmeier, Kathrin Scherer [3 ]
Leuppi-Taegtmeyer, Anne B. [2 ,4 ]
机构
[1] Univ Hosp Basel, Dept Infect Dis, Basel, Switzerland
[2] Univ Hosp Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland
[3] Univ Hosp Basel, Dept Dermatol, Allergy Unit, Basel, Switzerland
[4] Univ Hosp Basel, Dept Clin Pharmacol & Toxicol, Reg Pharmacovigilance Ctr, Basel, Switzerland
关键词
Rifampicin; Hypersensitivity reaction; Pneumonitis; Multi-organ failure; Pharmacovigilance; ACUTE-RENAL-FAILURE; DEPENDENT ANTIBODIES; HEMOLYTIC-ANEMIA;
D O I
10.1186/s40360-019-0289-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. Case presentation: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given. Conclusions: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost.
引用
收藏
页数:6
相关论文
共 26 条
[1]   Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[2]  
[Anonymous], 2015, LAB PHARM S A
[3]  
[Anonymous], 2017, PIL PROGR SICH MED S, P1
[4]  
BODMER M, 2009, SCHWEIZ RUNDSCH MED, V98, P179, DOI DOI 10.1024/1661-8157.98.4.179
[5]   Rifampicin-dependent antibodies bind a similar or identical epitope to glycoprotein IX-specific quinine-dependent antibodies [J].
Burgess, JK ;
Lopez, JA ;
Gaudry, LE ;
Chong, BH .
BLOOD, 2000, 95 (06) :1988-1992
[6]   Rifampicin-induced acute renal failure: a series of 60 patients [J].
Covic, A ;
Goldsmith, DJA ;
Segall, L ;
Stoicescu, C ;
Lungu, S ;
Volovat, C ;
Covic, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (04) :924-929
[7]  
Covic A, 2004, J INDIAN MED ASSOC, V102, P22
[8]   Rifampicin-associated acute renal failure: Pathophysiologic, immunologic, and clinical features [J].
De Vriese, AS ;
Robbrecht, DL ;
Vanholder, RC ;
Vogelaers, DP ;
Lameire, NH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (01) :108-115
[9]  
Díaz-Pollán B, 2013, REV ESP QUIM, V26, P369
[10]  
GUPTA A, 1992, INT J LEPROSY, V60, P185